Boston Scientific launches global restructuring plan with $700 million-$800 million in charges
BSX•Boston Scientific launches global restructuring plan
- Boston Scientific launched a global restructuring plan on July 21, 2026 to drive cost efficiencies and support strategic priorities.
- The program runs from 2026 through 2029, centered on supply chain optimization, production line transfers, and functional transformation.
- Total pre-tax charges are estimated at $700 million-$800 million, including $600 million-$700 million in expected future cash outlays.
- The company targets a reduction in gross annual pre-tax expenses of about $500 million as benefits phase in.
- Headcount reductions are expected, with savings largely earmarked for reinvestment in growth initiatives.
